Background: Almost one-third of Norwegian women aged 25-69 years invited to have a Pap smear do not attend during the recommended period, and thus constitute a population with highrisk of cervical cancer (CC). Since the incidence of precancerous lesions of the cervix peak with occurrence of pregnancies within the same decade in women aged 25 to 35 years of age, antepartum care presents an opportunity to offer a Pap smear thereby increasing the coverage of the programme. The study objective was to describe the effect of the antepartum Pap smear on the coverage of a cytological CC screening programme.
Background
Early detection of cervical cancer (CC) has reduced the mortality and morbidity of cervical cancer worldwide [1] , and it has been reported that both organised and opportunistic Pap smear taking has lowered incidence rates of CC [2] . However, the importance of obtaining and maintaining a high coverage within the target population has been unanimously recognised [3] [4] [5] [6] [7] [8] and several studies support the observation that the decrease in incidence rates is more evident in countries with organised screening programmes [5, [9] [10] [11] .
The Norwegian co-ordinated CC screening programme was introduced in 1995 and 71% of the women 25-69 years of age in Norway had a Pap smear in 1998 to 2000 [12] . More than 50% of the CC cases diagnosed however among the remaining group of non-participants, constituting a population at high-risk of cervical cancer [13] .
To minimize the costs of early detection of CC for society, only women without a normal Pap smear in a three years period are identified from the registry files and are invited to be screened [12] . Not all women attend following the invitation; in a Swedish study it was reported that nonattendance to cervical screening was positively associated with time-consuming and economical barriers [14] .
The peak age of incidence of pre-cancerous lesions of the cervix peaks with the occurrence of pregnancies in the age range 25-35 [15, 16] . From this perspective, antepartum care presents an opportunity to offer a Pap smear to women who otherwise might not go for routine health check-ups, and a means to increase coverage of the programme. Screening of this population can however cause "over-screening" given many of these women might have had a Pap shortly before the start of the pregnancy. Understanding the potential differences in the actual pattern of Pap smear taking activity among pregnant and non-pregnant women would help public health policy makers to recognise conflicting attitudes towards screening and to evaluate the effect of antepartum Pap smear as a routine activity.
The objective of this study is to describe the pattern of Pap smear taking activity and to estimate the impact of Pap smear screening in pregnant women on the overall coverage of the cervical cancer screening programme.
Methods

Subjects
All women resident in Norway in 31.12.1996 were identified from the Population Register. Women born before 1900, diagnosed with invasive cervical cancer or underwent hysterectomy before 1996, died in 1997, or had inadequate data for estimating the pregnancy duration were excluded (N = 39 707). The final study population consisted of 2175762 females and the personal identification number (PIN), a unique 11 digit code, identified the subjects.
The Norwegian co-ordinated CC screening programme A thorough description of the CC Screening programme is provided elsewhere [12] . Briefly, the Screening programme in Norway is built around the Cytology Register, which was established in 1992 to administrate the CC screening programme in Norway. It is mandatory to register PIN, date and result of every single Pap smear diagnosed in the country, irrespective of age of the woman, the nature of the health service (private/public) or the indication of the Pap smear. The PIN is used as a key for linkage between the Population and the Cytology Registry in order to identify all 25-69 year old women without a normal Pap smear during a period of three years, which is the recommended screening interval in Norway. From 1995 every women without a Pap smear in the period was identified on a monthly basis and they received personal invitations to participate. In this way, the opportunistic screening was integrated into the organised programme. To date information on more than six million Pap smears is available from the register.
The Medical Birth Registry of Norway
Established in 1967, the Medical Birth Registry of Norway (MBRN) was organised to conduct epidemiological surveillance of birth defects and other perinatal health problems in Norway aiming at prevention, as well as health services related to pregnancy, childbirth and the neonatal period, aiming at quality assurance. MBRN routinely registers the PIN and demographic information on the mother and the father, mother's health before and during pregnancy, including chronic diseases, complications during pregnancy and delivery as well as information on the infant, including birth defects and other perinatal problems.
Linkage between study population, MBRN and the Cytology Register
The PIN was used to gather information about pregnancies from the MBRN and previous Pap smears from the population-based Cytology Register for each subject.
From the MBRN records all 116 810 women who gave birth (or had abortion after the 16th gestation week) in 1996-7 in Norway (N = 121 400) were identified with information about exact date of birth, duration of the pregnancy, details about pregnancy outcome, multiple offspring, birth weight, and information on previous pregnancies. When there was more than one pregnancy registered per women for the period 1996-7 (2615 women had two and four women had three consecutive records during two years period) the first was included. For each study subject we identified the date and the diagnoses of the Pap smears from the Cytology Register. Subjects who received an invitation letter from the Cancer Registry of Norway were identified, together with the posting date of the invitation letter.
Study cohorts
We categorised the following three mutually exclusive cohorts, within the study population:
1. Pregnant women cohort (C preg ): subjects giving birth during the period ± 3 month from the date 31.12.1996. T 0 is the date denoting the start of the follow-up. For subjects within the pregnant women cohort, T 0 was the date when the antepartum period started, estimated individually for each subject as described above.
Reference cohort (C ref )
: subjects who neither gave birth nor were pregnant during this calendar period respective to the follow-up period of the pregnant women e.g. from 01.01.1996 to 31.12.1997. For the Reference cohort, T 0 , the date marking the start of the follow-up was randomly chosen for each subject from the same calendar period as for the C preg .
3.
Mixed cohort: all other subjects in the study population who gave birth in 1996-7 but were not included in the C preg .
Pregnant women and reference cohort were followed up for one year (since T 0 ) in the Cytology Register for Pap smears. To identify the pattern of attendance to screening for each subject, time since last Pap smear before T 0 was identified and stratified as the last Pap smear taken 1, 2, 3 or > 3 years earlier. To evaluate the response to the invitation letter, we identified subjects who received an invitation to screening and stratified analyses by the assessed time since the invitation was mailed in relation to T 0 , i.e. 24 to 2 months prior to T 0 , one month prior to 3 months after the T 0 , more than three months after the T 0 .
Statistical analyses
The Kaplan-Meier method was used to estimate the cumulative probability of having a Pap smear since T 0 . [17] We used unconditional logistic regression to compare the odds of having a Pap smear within 12 month after inclusion in the study for C ref and C preg . Odds ratios (OR) with 95% confidence intervals (95% CI) were estimated both crude and adjusted for age, screening history and time since invitation.
Results
Altogether, 24 297 women were assigned to the C preg , 2 060 118 to the C ref and 91 347 to the mixed cohort. For the three cohorts, age distribution, history of the Pap smear and history of the invitation are given in Table 1 (Table  2) . Overall, the proportion of women with Pap smears in the C preg was three times higher (68.7%) than the C ref (20.8% ).
Only women 15 to 44 years of age were included in the stratified analyses by Pap smear history, invitations and Kaplan-Meier analyses for estimating cumulative probability for having a Pap smear since T 0 . (Figure 1 
Discussion
We found that smear taking activity during pregnancy in Norway was high, with 69% of pregnant women having had a Pap smear during one year of follow-up. Most of the Pap smears from pregnant women were taken during the antepartum period, within 4 months from the start of the pregnancy, and therefore they will be further referred as antepartum Pap smears. Norwegian guidelines state that 1 st trimester antepartum Pap is recommended given no normal smear was taken during the period of 2,5 years prior to the visit [16] . This recommendation is given regardless of age because the average 1 st full-time pregnant Norwegian woman is 29 years old and should already been participating at the screening. However, 58% of pregnant women with a smear taken shortly before had also an antepartum Pap, reflecting the real-life situation, indicating poor adherence to the guidelines.
Effect of an antepartum Pap smear to the coverage
Compared to non-pregnant women, pregnant women were 4.3 times more likely to be screened by Pap smear during one year period, irrespectively of their age or screening history. As much as 76% of the pregnant women without a smear in three years prior to start of * 39 707 were excluded because they were either born before 1900, diagnosed with invasive cervical cancer and/or underwent hysterectomy before 1996, died in 1997 or had inadequate data for estimating duration of the pregnancy pregnancy had a smear in follow-up compared to 23% of the non-pregnant women. This large difference can partially be explained by the fact that more women in age of 15-24 years were included into the Reference cohort and therefore, should not have been screened at all. The age issues were taken into account by estimating the risk of a smear (adjusted for pregnancy status, age, or invitation) for women without the smear in three years period and for women who had smear shortly prior to the start of the study. It was somewhat surprising to observe that women without a smear within the last three years were less likely to have a smear compared to women who were screened lately, OR = 0.76. This figure can be explained by the observation that women with frequent smear taking activity were more likely to continue such a pattern, whereas women who had a smear taken rarely or never, were less likely to have a smear in the near future. One can postulate that one of the most important obligations of an organized CC screening programme is to minimise the proportion of women without a smear: and as a consequence, this risk estimate should eventually increase. As an example, pregnant women who had a last Pap smear more than three years prior to the start of the study, were 2.6 times more likely to have a smear in one year compared to women with a smear shortly before start of the study. The comparative figure for the non-pregnant women was 0.73. Together with the fact that pregnant women showed a higher probability of a favourable response to smear taking by invitation letter than nonpregnant women OR = 2.12 (95% CI 1.89 to 2.38) it implies that Pap smear in pregnancy increases the coverage of the programme.
Elucidating as to why almost two-thirds of non-pregnant women aged 15-44 years with an invitation letter did not have Pap smear, and why there was a three times higher attendance rate among pregnant women compared to non-pregnant women is important. Possibly an explanation lies in the relatively high work load of the women: they are usually either studying, have just joined the work force, have established a family, already have small children to tend to, or carry out a combination of these duties. The need for a regular check up for precursors of cervical cancer could be given less priority in such demanding/ real-life settings. This explanation is in line with a Swedish study, where Eaker concluded that non-attendance to cervical cancer screening is rather practically rooted. [18] A study from the U.S. identified no effect of either patient or physician reminders on Pap smear completion, while patients with a chronic illness had a three times higher probability of Pap smear completion, [19] indicating that access to health care is a lesser issue for those with chronic diseases.
Pap smear screening among women before screening age Only 32% of the pregnant women were < 25 years old and expected to be not screened due to young age. Women aged 15-19 had Pap smears in follow-up period more seldom than women aged 25-29 years, OR = 0.53. However, the probability of a smear was 66.1 % for pregnant women compared to 19.3% for non-pregnant women indicating that antepartum Pap contributed to increased screening among young women. In absolute terms, 1129 pregnant women aged 15 to 19 years had a smear during the one-year period. If all pregnant women in this young age group would have had a smear, the consequent number would have been 1706 compared to 25630 nonpregnant young women. It is clear that other factors than pregnancy seems also relevant in explaining the Pap smear-taking activity among young women. It should be remembered that a sexually transmitted virus, human papilloma virus, is responsible for developing pre-invasive cervical lesions and CC [20, 21] . Pregnant women irrespective of age therefore represent a population with a past or current exposure to sexually transmitted infections. However, many mild dysplastic cervical lesions are subjected to regress, as we have shown in our previous study on young women [22] , suggesting that mass-screening in young ages is unwarranted.
Does Antepartum Pap smear contribute to "overscreening"?
Altogether 32% of non-pregnant and 58% of pregnant women were classified as "overscreened", as defined by repeated Pap-smears in short period of time, emphasizing the fact that pregnant women taking an antepartum Pap cannot be solely the reason for the frequent screening observed. Further, the overall proportion of pregnant women in the population is small: expressed in the absolute numbers as much as 83 023 of non-pregnant compared to 5397 pregnant women underlines that the antepartum Pap does not substantially constitute to the overall number of extra smears taken.
In the current study in assessing the effect of pregnancy on coverage only we did not consider the possibility that Pap smears taken shortly before the start of the follow-up were abnormal, and as defined, that they should be followed up soon after with a Pap smear. Nor did we consider that the onset of clinical symptom(s) leading to a new Pap smear. These are relevant concerns that we cannot appropriately address in this study design. However, there are no strong reasons to suspect large difference in the two cohorts in these respects. Taking into consideration that the proportion of abnormal Pap smear is low in the programme: approx. 86% of all the smears are normal, and any existing differences in the distribution of abnormal smears in the pregnant and non-pregnant women are likely to be only weakly affect the estimates of coverage.
It is natural combine the antepartum visits with the distribution of the health education among women and several authors demanding the routine antepartum smear [23, 24] in order to improve diagnosis of the CIN. However, the decision on recommending Pap smears for all pregnant women should be based on information on the accuracy of the antepartum Pap to diagnose underlying pre-invasive lesion, the impact on coverage and on the mean ages of pregnancy in given country.
Conclusion
Several studies have been performed to assess the value of a Pap smear collected during the antepartum and/or postpartum period. Conclusions regarding the necessity of routine Pap smear(s) during pregnancy are often missing or, sometimes contradictory, reflecting that information on availability or history about cervical cancer screening is often unavailable. This registry linkage study has been conducted to estimate the effect of Pap smear during pregnancy on the coverage, and our study suggests that the provision of Pap smears to all pregnant women in Norway will increase the coverage of the programme. The contribution of such an action on over-screening and screening among young women is likely to be modest in the country where in the average, women become pregnant after the recommended age of screening. 
